Market Analysis — MONTEFIORE NYACK HOSPITAL
NY market | 4 hospitals | HHI: nan (Competitive)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
4
Hospitals in Market
910
Total Beds
$0.7B
Market Revenue
Competitive
HHI: nan
None
Moat Rating (4/10)
#2
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantageweak
Switching Costshigh
Market Share42.5%
Top 3 Concentrationnan%
Network Density0.44
Margin vs Market-0.0%
Bed Util vs Market+19.6%
What This Means
This hospital has a none moat — no moat — commoditized market position, pricing power limited. The NY market is competitive — many players, value creation must come from operations not market power (HHI: nan).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full NY market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| GOOD SAMARITAN HOSPITAL | 286 | $352M | 50.0% | 31.4% |
| HELEN HAYES HOSPITAL | 0 | $52M | 7.4% | 0.0% |
| ROCKLAND P.C. | 415 | $nanM | nan% | 45.6% |
Regional Payer Mix
■ Medicare 25%■ Medicaid 11%■ Commercial 64%